Home → News & Events
Subscribe to our newsletter to stay up to date on the latest news, receive updates and invitations to events.
📢 Have you already added the 3rd TETRIS webinar to your agenda?
Join us for the third webinar of the TETRIS Educational Series, taking place on:
🗓 Thursday, 26 March 2026
⏰ 13:00–14:00 CET
The session will be presented by Ana Vega and Miguel Elías A. from Fundación Pública Galega de Medicina Xenómica (FPGMX).
The webinar will explore how transcriptomics can support personalised risk assessment and contribute to improving the safety of radiotherapy treatments within the TETRIS project.
🔓 The webinar is open to everyone.
👉 To join the session, click here: urlr.me/MaBKQ4.
We look forward to welcoming you to the third appointment of the TETRIS Educational Series!
The importance of the right words.
In Radiotherapy the use of the right terminology is important for a clearer communication and reducing unnecessary alarm among patients, caregivers, policymakers, the media, and colleagues outside this specialty.
A better wording does not weaken science; rather, it can support informed consent, shared decision-making, and public trust in RT as a curative, organ-sparing, high-value therapy.
For this reason, when we talk with patients and the public, but also inside the radiotherapy community and in scientific papers, we should use
* “Side effects” or “Adverse events” instead of “Toxicity”
* “Dose guidance” instead of “Dose constraints”
* “Organs of interest”instead of “Organs at risk”
* “(Set-up) variations”instead of “(Set-up) errors”
Patient-centered terminology can make a difference by complementing technical advances and strengthening trust without compromising scientific precision.
Read more here: https://www.linkedin.com/pulse/radiotherapy-cures-cancer-words-can-help-us-cure-ynoe-de-moraes-wznpc/?trackingId=5SrQkKbSQw6KzXlsn1KcfQ%3D%3D
🎥 TETRIS Educational Series: Webinar Recording Available
Did you miss the second webinar of the TETRIS Educational Series?
The session “Methods for assessing imaging biomarkers in breast cancer radiotherapy within the TETRIS project”, presented by Claudio Fiorino and moderated by Tiziana Rancati is now available online.
In this lecture, he explored methodological approaches for assessing imaging biomarkers and radiomics in breast cancer radiotherapy, highlighting their role in supporting personalised risk assessment and safer treatment pathways within the TETRIS project.
▶️ Watch the full webinar recording on YouTube: https://www.youtube.com/watch?v=FFN0XA_b8RQ
📑 Download the presentation slides accessing the news on our website.
🔗 To read the news and access the materials, click here: urlr.me/sru258.
#TETRISproject #Education #Radiomics #MedicalImaging #Radiotherapy #CancerResearch #DigitalTwins #HorizonEurope
@unisr Università Vita-Salute San RaffaeleFondazione IRCCS Istituto Nazionale dei Tumori @istituto_tumori
📢 TETRIS Educational Series, 3rd Webinar
We are pleased to announce the third webinar of the TETRIS Educational Series, which will take place on
🗓 26 March 2026
⏰ 13:00–14:00 CET
The session will be presented by Ana Vega and Miguel Elías A. from Fundación Pública Galega de Medicina Xenómica (FPGMX).
In this webinar, the speakers will share insights from their work within the TETRIS project, highlighting the role of transcriptomics in advancing personalised risk assessment and improving the safety of radiotherapy treatments.
🔓 The webinar is open to everyone. Stay tuned for more details and connection information.
